Leprosy is a chronic infectious disease which presently affects more than 15 million individuals. The disease is the result of the interaction between Mycobacterium leprae and the immune system of the infected host, M. leprae by itself being a virtually harmless bacillus. Apparently the majority of individuals exposed to or infected with M. leprae develops effective immunity to M. leprae without disease. A minority, however, may develop a wide range of clinical symptoms, which show striking interindividual variability. This clinical spectrum closely parallels the immunological spectrum of responsiveness displayed by the host [1,2].
KeywordsCoeliac Disease Recombination Fraction Clinical Type Leprosy Patient Healthy Sibling
Unable to display preview. Download preview PDF.
- 2.Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity. A five group system. Int J Lepr 34: 225–273Google Scholar
- 3.De Vries RRP, van Eden W, Van Rood JJ (1981) HLA- linked control of the course of M. leprae infections. Lepr Rev 52 suppl 1: 109–119Google Scholar
- 5.Van Eden W, de Vries RRP (1984) HLA and leprosy: a re-evaluation. Lepr Rev 55: 89–104Google Scholar
- 6.De Vries RRP, van Eden W, Ottenhoff THM (1984) HLA class II immune response genes and products in leprosy. Prog Allergy (in press)Google Scholar